Related Experiment Video
Updated: May 22, 2025

08:22
Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids
Published on: August 11, 2017
15.7K
3D bioprinting technology for modeling vascular diseases and its application
Ju-El Kim1, Gun-Jae Jeong2, Young Min Yoo3
1Department of Systems Biotechnology, Chung-Ang University, Anseong-Si, Gyeonggi-Do 17546, Republic of Korea.
Biofabrication
|March 13, 2025
Summary
3D bioprinting advances vascular disease modeling for drug screening. This review covers bioprinted models of atherosclerosis, thrombosis, aneurysms, and tumor angiogenesis, highlighting future clinical applications.
Area of Science:
- Biomedical Engineering
- Vascular Biology
- Regenerative Medicine
Background:
- In vitro vascular disease models are crucial for drug screening and mechanistic studies.
- Bioprinting offers high-resolution 3D capabilities for recapitulating native tissue structures and physiological characteristics.
- Blood vessels exhibit complex layered structures and respond to mechanical stimuli like shear stress.
Purpose of the Study:
- To review the physiology of blood vessels and pathophysiology of vascular diseases.
- To discuss recent advances in fabricating in vitro 3D vascular disease models using bioprinting.
- To address challenges and future perspectives for clinical translation of bioprinted vascular models.
Main Methods:
- Review of existing literature on vascular disease modeling and bioprinting techniques.
- Analysis of bioprinting strategies for incorporating cellular components, geometrical properties, and mechanical stimulation.
- Discussion of specific vascular diseases including atherosclerosis, thrombosis, aneurysms, and tumor angiogenesis.
Main Results:
- 3D bioprinting enables the creation of sophisticated vascular models that mimic native tissue complexity.
- Bioprinted models can incorporate multiple cell types, structural features (curvature, branching), and mechanical cues (shear stress, pulsatile pressure).
- Recent advances have improved the fidelity of in vitro vascular disease models.
Conclusions:
- Bioprinting holds significant potential for developing advanced in vitro models of vascular diseases.
- These models can enhance drug screening efficacy and mechanistic understanding of vascular pathologies.
- Further development is needed to overcome current challenges and facilitate clinical translation for therapeutic interventions.

